newsfilter
← Latest News
GlobeNewswire·

Sorrento Issues Supplement to its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stock

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento")) today posted a supplement to its previously issued "Frequently Asked Questions" document under the "Investors" section